KING'S BENCH DIVISION
ADMINISTRATIVE COURT
SITTING IN LONDON
B e f o r e :
____________________
THE KING (on the application of DAISY SIMPSON) |
Claimant |
|
- and - |
||
NHS MID AND SOUTH ESSEX INTEGRATED CARE BOARD |
Defendant |
____________________
Lee Parkhill (instructed by Mills & Reeve) for the Defendant
Hearing date: 14.11.24
Draft judgment: 25.11.24
____________________
Crown Copyright ©
FORDHAM J:
Introduction
The Claimant
Daisy is a 35-year-old lady that lives alone in a one bedroomed flat in Brentwood. She is currently in receipt of a personal health budget with which she employs carers over a 24-hour period. Daisy has a long history of mental health disorders diagnosed at the age of 17 and numerous physical health conditions including Diabetes, Gastro issues, Gynae issues, Chronic Lung Condition, Moya Moya disease, Recurrent Trans Ischemic Attacks (TIAs) and Sleep Apnoea.
Daisy has multiple interventions to support her breathing including BIPAP, Nebulisers six times daily, a four weekly intravenous infusion, a flutter device (a type of cough assist) and oral medications. Her fluctuating physical abilities mean that she often struggles to manage these interventions without support from her carer. Her carer also prepares all meals for Daisy and when she is present will also serve them to her. Daisy reports that she experiences intermittent swallowing problems especially following a TIA. Currently Daisy can access the toilet to pass urine and open her bowels however, she suffers from both incomplete emptying, requiring intermittent self-catheterisation at least once daily, and bowel dysmotility causing her issues with constipation that did require self-administration of enemas, however, this now appears to be managed with administration of Bisacodyl oral tablets. Daisy is at risk of skin deterioration due to her reduced mobility and as a side effect of oral steroids. She requires assistance from her carer to maintain her skin integrity. She has pro shield barrier cream applied at least twice daily. Daisy has a history of having suffered a stroke leaving her with left sided weakness. She is, however, still able to weight bear using pivot transfers although she stated that this is becoming more difficult each time, she has a further TIA. Currently Daisy requires the assistance of one to two people to assist her with the transfers. No falls have been recorded. Daisy has an electric wheelchair which she can drive herself once she has been assisted into position. Currently this is only used for outside purposes as her home is reported to be too small for wheelchair use.
Daisy can verbally communicate clearly and articulately although she can intermittently suffer with mumbled speech especially after a TIA. Currently Daisy is orientated to time, place and person and has good insight into her impairments however, her memory is reported to have been worsening of late to the extent that she now requires prompting with all day-to-day activities. Daisy denies any challenging behaviour and states that she will only say no to something if she feels that she is being put at risk.
Daisy has a complex medication regime which she currently manages herself with assistance from her carer although she stated that she is finding this more difficult. She has purchased an Insulin Pump and a constant glucose monitor to manage her diabetes. She requires assistance from her carer to fill and set up the pump and from her carer to enter carbohydrate amounts and blood sugar readings into the pump for it to calculate bolus doses. Daisy is prescribed Codeine to manage her pain however, she reports that this is ineffective, and she suffers constant pain. Oramorph is prescribed for breakthrough pain relief and Daisy can request this from her carer when needed. Daisy has also recently been diagnosed with Endometriosis which causes her to have heavy bleeding from her vagina. She requires assistance from her carer to manage this at times. Daisy is extremely difficult to cannulate and has now had a portacath inserted for easy vein access.
Daisy suffered a stroke in 2021 and has been diagnosed with Moya Moya disease which limits the flow of blood to her brain and puts her at risk of further strokes. Daisy stated that currently she is having TIAs daily which temporarily affect her speech, mobility, and cognition. Daisy has multiple conditions affecting her daily life : Moya Moya disease (under the Bristol, awaiting cerebral vascular bypass operation); Admissions to Queens with stroke and sub-arachnoid haemorrhage; Brittle asthma (under Brompton Hospital); Obstructive sleep apnoea (BIPAP) (under the Brompton); Diabetes Mellitus (presumed type 1, insulin treated, supported by the diabetic nurses); Recurrent episodes of elevated lactate levels (uncertain cause); Schizoaffective disorder; Migraines; Cushing's syndrome from previous long term steroid use. Presumed adrenal suppression due to long term high dose oral therapeutic steroid use; Progressive multiple fatty lumps; Emotional Unstable Personality Disorder. Daisy is known to multiple services including: Neurosurgeon; Respiratory physician; Gynaecologist; Ophthalmologist; Consultant neurologist - Dr De Silva; Dermatology; Diabetes and Endocrinology - Basildon and Thurrock Hospital; Occupational Therapy for support and equipment.
I have a life expectancy prognosis of 1-2 years. So, for every minute that passes, I am dying. My already vastly reduced life expectancy is diminished for every day that I am not able to receive a personalised package of NHS Continuing Healthcare that meets my physical and mental health needs in the immediate future I have a number of complex diseases which are so rare that, statistically, finding someone who understands my needs is nigh on impossible. For example, I have a condition called Moyamoya disease, which affects only one in every million people. This causes me to suffer from 17 Transient Ischaemic Attacks ('TIAs' / strokes per week (i.e., 3 per day), which significantly hampers my quality of life. Any of these stroke episodes could ultimately prove fatal.
Amongst other conditions, I have severe asthma; excessive dynamic airway collapse; type 1 diabetes; and sleep apnoea, for which I receive a large amount of medication and medical equipment that needs to be administered every day. My medication dosages change and titrate daily. I have different antibiotic regimen and steroid doses. I have some medications that must be given in an emergency and are time sensitive. Carers alone cannot make the clinical judgments to respond to the different needs in a safe way. I have multiple different clinical needs. To treat me and give me the correct medication, there needs to be ongoing clinical assessment. There is no way to care plan all my 30+ healthcare conditions that reduces the need for clinical judgement.
My carers are having to administer medication to me, despite having no clinical expertise. I receive high-risk medication for example, insulin, morphine, and codeine none of which is clearly documented. This has meant that my carers have overdosed me with insulin and morphine due to not anticipating the complexity and intensity of my needs. My medication regime often changes on an hourly basis. Without 24/7 nursing provision to ensure that my care regime is safe, I am terrified that my carers could overdose me. If my carers walked in and found me drowsy which is not unusual, given my needs that could stem from multiple different clinical needs; or even a combination of needs. For example, stroke, brain bleeds, seizure, hypo, hyper, adrenal suppression / failure, infection, and respiratory failure. In my case, these all have different management and treatments; and if the carers treat me for a stroke and miss a hypo, my conditions then end up mimicking each other. It is too high risk for carers to be making judgments unaided.
Given the rarity of my conditions, whenever I seek care from healthcare professionals from day to day, they generally do not have the experience and do not understand any of my conditions. It is difficult to find someone else like me across the board. That makes the issues in my care challenging because there is no set standard for what the care should be as it is so rare and complex, professionals have no benchmark, no comparator, on which to base my needs. So, many of the complexities in my care stem from the diseases I have got being very difficult and very rare, based within a system that is not set up for someone with the level of rarity and complexity of my diseases.
So, a lot of my care is based at national services: tertiary care providers. Tertiary care providers are removed from secondary care services they are highly specialised. In adult care, they are generally spread out across the country. Most adults, if they are unfortunate, would end up under just one or two of these specialised services. Due to the uniqueness of my conditions, I have ended up under multiple specialist services spread out across the UK all dealing with professors and specialists who are top of their field in their area. However, this has left a massive crater in my care at a local level because my needs are deemed "too complex" for secondary care which is what the ICB commission and what local services commission so that is why I am under national providers. However, the national providers are also terrible at speaking to each other as they are all under different systems (for example, System One, System Two, EPIC, amongst others).
Part of the breakdown in my care is not just the complexity and the actual conditions themselves, but also how those conditions are managed and how they are now spread out across the entirety of England. There is no professional bringing this together; and so, complexity is used within that to deny needs and pass the buck onto different sectors of the NHS. It strikes me that the ICB has done this time and time again in order to deny the full scope of my needs. It tells me to speak to my GP, who then refers me to other services within the NHS, who cannot assist me on grounds of complexity.
I am under something like 35 different clinical teams. Every time I see a doctor, they refer me to another set of doctors hence why I am under so many different people. I am having to travel frequently to London, Cambridge, and Bristol. I am travelling almost all the time. As part of my previous care and support plan, I was getting overnight stays for hospital trips. I was also getting transport costs covered. This was agreed due to the sheer amount of ongoing hospital appointments I have got. At the time the ICB assessed me, I had 18 appointments in 30 working days. These were long-distance appointments. Some weeks, I am at multiple appointments in one week. It has not been unheard of where I have been in London, Cambridge, and Bristol all in the same week
The Flat
Previous Care Coordinators
The PA
I am Daisy's Administration Support as the administration side of Daisy's complex situation is substantial as you can imagine. I also cover everything HR related. (Employment, Contracts, Sickness, Holiday, etc). I was initially employed to take the pressure from Daisy and deal with all paperwork, arranging clinical appointments, and supporting Daisy with anything Administration related. It quickly became apparent that she needed help with HR Duties and a Lot of complaints/issues etc which in turn took over my role completely. I find that most days we are dealing with issue after issue, [setback] after [setback], chasing professionals for responses, begging for help on Daisy's behalf. This was taking me away from what I was employed for on 30 hours a week. I work around 40-45 [hours] per week for Daisy now in order to complete what is needed and even then it's not always completed. I have worked in one of the busiest NHS A&E departments and I can honestly say that I am far busier In this role for Daisy, the paperwork and complex nature of everything makes it a lot more chaotic and I would hate to think how Daisy would be coping without me.
The Office Space
Daisy rented an office space within a 1 min walk to her flat. She did this for the following reasons The confidential paperwork that I deal with daily would have been lying around in my house and I do not have space for an office. My house is a very busy house with 1 teenager and 2 small children. All paperwork is now safely filed at the office and can be referred to easily. It's within a 1 min walk to Daisy so I can go and consult with her as necessary. Carers can come there for breaks/shower and changeover etc, this saves more people than necessary being in Daisy's flat at one time. Weekly Team meetings are held in the office. Job interviews are done in the office. The office space has been a great addition to the team in every way.
Office space Ms Duggan and [Ms Simpson's] carers utilise the office space it is used predominantly for team meetings, HR meetings, disciplinary concerns, interviewing new care staff, confidential telephone calls, vetting, training, and storing confidential paperwork. You will be aware that privacy is of the utmost importance to Ms Simpson She has also been trapped in one room for the last three years; hence, she would not be able to fit two carers and a clinical case coordinator into her flat. Otherwise, Ms. Simpson considers that she would be exposed to safeguarding risks; for example, she would have to interview new care staff and manage the administrative aspects of her care provision from her bed, which is an unjustified interference with her personal space [T]his goes directly to her health and wellbeing outcomes.
CHC
Use of community services. 6.3.13. PHBs should not be used to purchase services that the ICB already commissions, including community health services and equipment. Any exception to this would need to be considered by the ICB on a case-by-case basis. 6.3.14. During the care and support planning process the individual (or their representative) will be informed of existing NHS services.
Direct Payments
The enclosed plans do not contain any provision beyond that which the ICB has determined is reasonably required to meet assessed needs. If the Claimant would like to discuss the detail of the plans and/or explore the option of including additional provision within the PHB plan aimed at enabling her to achieve health and wellbeing outcomes, then the ICB is happy to engage with her, via email for that purpose.
As a general principle, the ICB will only fund this additional provision from within the indicative budget financial envelope. This is because the indicative budget reflects the cost of the care the Claimant is assessed to require were it to be commissioned directly by the ICB. The indicative budget therefore provides both a financial envelope which is adequate to meet assessed need and a way for the ICB to manage its finite NHS CHC resources equitably for all NHS CHC recipients.
Public Law
(1) When it assesses needs and identifies arrangements to meet needs, an ICB is entrusted with making evaluative judgments: about what the individual's reasonable requirements are; about what services and facilities are appropriate to meet their relevant needs; and about what services or facilities for care are appropriate as part of the health service. These are all evaluative judgments for the ICB as the primary decision-making authority. The High Court has no function of substitutionary review. Instead, the Court applies conventional standards of reasonableness review, See Wahid v Tower Hamlets LBC [2002] EWCA Civ 287 [2003] HLR 2 at §33; and Lambeth LBC v Ireneschild [2007] EWCA Civ 234 [2007] HLR 34 at §44.
(2) Those conventional standards of reasonableness review involve asking: (a) whether the outcome is beyond the range of reasonable responses; (b) whether the reasoning process involves a recognised species of error of approach (eg. an error of logic or the disregard of an obviously relevant consideration); and (c) whether there was an insufficiency of reasonable inquiry. See R (Law Society) v Lord Chancellor [2018] EWHC 2094 (Admin) [2019] 1 WLR 1649 at §98 (as to (a) and (b)); and Balajigari v SSHD [2019] EWCA Civ 673 [2019] 1 WLR 4647 at §70 (as to (c)).
(3) Decision documents including needs assessments and care plans are read and approached with an understanding of their nature and function, avoiding over-zealous or legalistic examination. See Ireneschild at §57.
(4) A judicious balance must be struck. On the one hand the necessary intensity of review is high and the scrutiny close, given the profundity of the impact and since provision of a global sum may make a failure to meet eligible needs less visible. On the other hand, the judicial review court must respect the functional distance between primary decision-maker and secondary reviewing court, recognising the prospect of judicial blind-spots and avoiding inappropriately over-exacting demands. See R (KM) v Cambridgeshire County Council [2012] UKSC 23 [2012] PTSR 1189 at §36.
These Proceedings
About the Decision-Making Process
The ICB committed to continuing the care and support planning exercise with a completion date planned for 12 April 2024. Ms Simpson was to provide further information or evidence for consideration by 15 March 2024 and that fact was recorded on the face of a court order. This was to give Ms Simpson time to gather any information and the ICB sufficient time to consider it. Ms Simpson declined requests for a meeting in person or remotely and requested the ICB only communicate with her via email, predominantly via her personal assistant Ms Duggan. Ms Simpson's lawyer expressed that such a request should be accommodated as a reasonable adjustment. The ICB agreed to accommodate this request. Ms Simpson's solicitor filed a witness statement on 8 March 2024 exhibiting various documents which the ICB were to consider as part of its review, which it did. Ms Simpson also continued to supply information in support of her views as to needs beyond 15 March 2024, to which the ICB has continued to have regard. Additionally, as part of the care and support planning process, registered nurses Kim Oddy and Nicola Wood, who are the ICB clinical case managers assigned to Ms Simpson, contacted professionals involved in Ms Simpson's care and treatment for further clarification around care plans and Ms Simpson's needs. They also reviewed her electronic records on the SystmOne and Broadcare systems, as well as the documents submitted by Ms Simpson and the review from September 2023. Nicola Wood emailed Ms Simpson via her personal assistant Charlotte Duggan for any information gaps that they were unable to find and to seek clarification on information as needed and information provided informed the process. Kim Oddy, to prepare draft PHB plans, contacted Ms Simpson via Charlotte Duggan to identify her current staff and pay rates, what PPE Ms Simpson requires, the costs of PPE, her payroll provider and the associated costs. Kim Oddy requested the cost of the Payroll services three times, but has not yet received this information. Kim Oddy also worked with the brokerage Purple to prepare two draft PHB plans, one using Ms Simpson's current rates of pay and one at the market rate. Professionals contacted included, Ms Simpson's Occupational Therapist, Speech and Language Therapist, her GP practice, her specialist Moya Moya Consultant, her Diabetes team, NHS Continence Services and the respiratory specialists at Royal Brompton regarding asthma. The ICB also had regard to recommendations in the independent review it commissioned regarding Ms Simpson's needs and care and support within the period of 7th March 2022 to 31 May 2023.
Fresh Evidence
Alternative Remedy
The Package of Care in Overview
[i] Co-ordinate appointments ie. all admin involved including phone calls. [ii] Liaise with medical teams to co-ordinate care ( including provision of equipment ) and ensure all teams have up to date information. [iii] Attend hospital and other medical appointments. [iv] Supervise and support PAs including ensuring all staff training is up to date, they have completed care competencies and online/face to face training, complete rotas, support with timesheet completion and any other admin relating to staff that is required. [v] Escalate any medical concerns to the appropriate teams. [vi] Collate/write care plans and ensure all information in them is keep up to date in consultation with other relevant professionals.
Nursing Care
(1) The Defendant's impugned decision of 12.4.24 fails lawfully to address the Claimant's relevant needs for the care of a nurse within her home. The Claimant has a clearly evidenced need for nursing care, which moreover needs to be around the clock (24/7). A 30-page schedule of unmet needs from the Claimant and her care team dated 2.4.24 clearly describes 24/7 nursing provision as needed in relation to the following medical conditions or needs: ventilation; increased strokes/respiratory; infection lungs (including bloods, IV medication when required and fluids); strokes/TIAs (including IV fluids when needed); swallowing issues; communication issues; pain; endometriosis (including IV as required); the overall need for 24/7 nursing care (including ability to access IV fluids); bloods; and IV access. The Defendant has failed to identify any need for any nursing care, still less the 24/7 nursing care which is evidenced as needed. The CCC role description does not make any reference to the CCC undertaking any nursing care. The suggestion that if necessary - the CCC as a trained nurse could take the Claimant's bloods via the portacath is made for the first time in witness statement evidence.
(2) There is the position as to dangerous drugs. There was clear evidence before the Defendant about the serious implications of dangerous drugs in the hands of unequipped carers. The Claimant's solicitor put forward a report by Lynn Jones at Health Advocacy (28.11.23) which described
a number of life-threatening occasions where Daisy has received the incorrect medication or treatment as the carer was not equipped to manage the complexity of the situation.
The Plan does not acknowledge the risks from dangerous drugs and does not even include Oramorph (morphine) within the 20 medications said to be "listed for the month of August 2023" on SystmOne (a clinical computer system); which fits with a pre-action letter of response (23.2.24) which had said: "There is no record of the Claimant being on morphine in possession of the ICB". Dangerous drugs need nurses to administer them.
(3) There is the position as to IV respiratory medication. The Plan identifies no provision for nursing care, including in relation to drug therapy and symptom control where the IV box is checked as applicable and the provision is a carer. Carers cannot administer IV respiratory medication. The Plan says:
IV respiratory medication is administered via the portacath in a clinical environment only (The Royal Brompton).
The point is that this would be administered in the home, except that the Defendant has failed to make provision for this. A post-decision letter of 24.6.24 from the Respiratory Consultant at The Royal Brompton to the Claimant's GP says: "we aimed to provide an antipseudomonal intravenous antibiotic at home". A post-decision email of 1.7.24 describes arrangements for "IV training for home antibiotics" with a "designated person". The Claimant's third witness statement (31.10.24) produces a plan on 8.4.21 for Basildon University Hospital to deliver, by its Hospital at Home team, IV Ceftriaxone. All of this is legally relevant fresh evidence, to demonstrate that there was no reasonable enquiry and to show what a reasonable enquiry of The Royal Brompton would have elicited.
(4) Finally, there is the position as to IV fluids. The Plan says:
Monthly infusions for Asthma at the Royal Brompton. Daisy advised that she requires IV fluids in the community but there is no supporting evidence regarding the indication for this and Daisy's GP has advised via email that - IV fluids cannot be prescribed and monitored safely in primary care.
The point is that the Defendant has confused a "who" question with a "what" question. The relevant email from the GP's surgery (which was dated 26.2.24) was recognising the "what" (that IVF fluids in the community were indicated) and the "who" (that prescribing would need to be by The Royal Brompton). In that email, the GP Practice Manager had written:
I didn't go back to the ICB in the email about the IV fluids as we were asked at a meeting about it and we said that although we were aware you needed them it is not something we can prescribe in Primary care as its not available for GPs to prescribe - it's just not on the system - Brompton or whoever said you needed it originally would need to prescribe it as needs to come from a consultant.
This email was in the Claimant's solicitors' representations bundle, together with a witness statement from the solicitor Mr Peters who described this as a document which:
states that the Claimant does require IV fluids but that it is not prescribed in primary care; therefore, the ICB would need to engage with her consultants at Brompton Hospital.
This alerted the Defendant to an inquiry which was reasonably required and which Ms Lowe's first witness statement asserts but without any supporting evidence was undertaken. The Defendant does not suggest that IV fluids can be administered by a trained carer or the CCC.
(5) In all these circumstances and for all these reasons, the Defendant's decision as to nursing care was outside the range of reasonable responses or involved a failure of the public law duty of reasonable enquiry.
(1) The impugned decision letter started with this:
In producing this document, the ICB has considered the further material provided by the Claimant in addition to reviewing material on her SystmOne records and information provided by professionals involved in her care and support. The ICB has not found the Claimant to have an assessed need for 24-hour nursing care.
That was an evaluative judgment, as was the Defendant's consideration of various elements of needs and care.
(2) The CCC was specifically designed to be a qualified nurse, whose hours were costed as "Clinical Case Manager" and "Nurse Support".
(3) The letter of response of 23.2.24 is not a basis for a finding that the Defendant was in error as to morphine when it made its later decision on 12.4.24, giving an inclusive list (medication "includes"), and including an express statement elsewhere in the decision that "Oramorph is prescribed for breakthrough pain relief".
(4) The point made by Ms Jones about medication needs to be seen in its setting. As the Claimant's solicitor's witness statement of 6.3.24 accurately characterised it, the Jones report "outlined the critical elements of the Claimant's care and recommended an experienced nursing coordinator". The Jones report described Katie McIlroy's previous role. That was the context for the point made by Ms Jones about drugs. Ms Jones said:
Since the removal of Katie McIlroy (Care Coordinator) by the Mental Health Team there have also been a number of life-threatening occasions where Daisy has received the incorrect medication or treatment as the carer was not equipped to manage the complexity of the situation. No one has been put in place to take up all of the things Katie was doing and consequently the organisation around her care is in total chaos.
Ms Jones went on to explain why a Nursing Care Coordinator was an essential requirement to provide: a Daily Care Plan which is cohesive and responsive to all medical and practical events; coordination of medical appointments including liaison with hospitals and clinical departments to ensure they fully prepared and have access to Daisy's care records; support for care staff for the more complex tasks resulting from unplanned daily events; training of care staff in the use of equipment which they may be unfamiliar with; and management of complex care provision.
(5) The Plan describes the CCC role as being "in line with the recommendation contained in the independent review and GP recommendation for a full time position". The GP's recommendation was in a letter dated 18.10.23 which described as beneficial "a nurse to support her care team", as a "case manager" who would "bring Daisy's care together", being someone with a clinical background to carry out this role given the Claimant's complex health needs. The independent review was a 30-page report dated 7.2.24, accurately described by the Claimant's solicitor as a review which "recommended the Claimant's need for nursing oversight". The independent review was recommending the following:
A dedicated clinical resource could provide care coordination, support to avoid escalations or better manage escalations in care by monitoring and providing advice to the PAs delivering day-to-day care. In addition, some key tasks that cause issue such as the drawing of blood from the Individual's Port could be fulfilled by this function.
Given the express reference in the Plan to this independent review recommendation, it is unsurprising that Ms Lowe's witness statement should describe the CCC, if necessary, taking bloods.
(6) The Plan records that specific consideration was given to both IV respiratory medication and IV fluids. As to IV fluids, it was correct that the GP Practice Manager had advised that IV fluids could not be prescribed and monitored safely "in primary care" (ie. by the GP). That is the "who". The Claimant's solicitor said the GP Practice Manager was stating that "the Claimant does require IV fluids". But that could only be a secondary understanding, as seen in the Practice Manager's references to "Brompton or whoever you said needed it". The Defendant was entitled to ask itself whether there was "supporting evidence regarding the indication for this". What had been elicited was that the Claimant had monthly infusions for asthma at The Royal Brompton. There are the post-decision communications from The Royal Brompton dated 24.6.24 and 1.7.24. But these are about IV antibiotics. And what this evidence shows is that The Royal Brompton's plan for IV antibiotics at home could be delivered by a carer with suitable training, which The Royal Brompton was arranging (1.7.24), as is the understanding described in Ms Lowe's third witness statement (7.11.24).
(7) I am unable to see any unlawfulness in the Defendant's approach to nursing care. I accept the submissions of Mr Parkhill on this part of the case.
The PA
The Office Space
The use of the office space has helped manage boundaries for me. We use the space for team meetings. Conducting interviews. Training (when we all fit). HR issues - if I have to tell staff off or issue a warning it is difficult to do that from my bed. The carers go sometimes when they need time out of / break- there is a kitchen, showers. It's 40 seconds away. The calls that could cause are distress are taken there removing me from the conflict. Admin is based there.
I accept that the Claimant's home is small and that the office space is a considerable advantage. The decision letter emphasises that the office space "is not approved" adding that it does not feature in any iteration of the Claimant's care and support plan. I am unable to characterise as unreasonable as understood in public law the Defendant's failure or refusal to accept that the Claimant's home is an insufficient space for the delivery of the services to meet her needs, such that the Defendant has the responsibility to pay for a further room; still less any failure or refusal to accept that this is accommodation appropriate as part of the health service. The CCC's job description does not require full-time presence in the Claimant's home. There is no unreasonableness or illogicality in Ms Lowe identifying some tasks as capable of being performed from home or remotely. The Defendant has identified what is accepted as being the right question: whether the office space is reasonably required to meet an assessed health and care need. It has in my judgment answered that question reasonably. I am unable to see any unlawfulness in the Defendant's approach to the office space. I accept the submissions of Mr Parkhill on this third part of the case.
Massage Therapy
Slidesheets
Wheelchair
(1) The first problem is that the alternative route is tried, tested and has failed. The Claimant's solicitors had explained the position in an email on 25.3.24 (attaching a complaint letter dated 30.8.22):
Wheelchair We are informed that our client has never declined a referral for NHS wheelchair services see complaint letter attached. As acknowledged in the ICB's Letter of Response, Ms Simpson was seen by wheelchair services but did not meet their criteria for an electric wheelchair on the basis that she had recurrent strokes. The wheelchair offered to her which was unsuitable for her needs was declined. Our client considered this was a blanket policy (as it failed to take into account her specific circumstances) and was unlawfully discriminatory on the grounds of her severe disabilities. She was then discharged from wheelchair services, and the ICB initially refused to fund the wheelchair within her PHB. However, an 8-week hire agreement was funded by the ICB until an alternative had been sorted. In light of her discharge from NHS wheelchair services, that never materialised; hence, from our client's perspective, the ICB's agreement to fund her wheelchair remains live.
That means a case-by-case exception is reasonably needed, as described in the Defendant's PHB Policy at §6.13.13.
(2) The second problem is that the Defendant's insistence on funding a wheelchair only through the NHS referral route is linked to an exaggerated point about safety. The Defendant has relied on an email dated 26.9.22 from the LTCC Senior Manager Sue Patterson to Ms Lowe, which says:
Looking at some of DS medical diagnoses we would also have concerns long term is there is further cognitive deterioration as to whether DS could manage a powered chair. Also for [noting] should DS have any seizures the powered chair would no longer be able to be left with DS for her own and others safety. This is the same practice as with a driving licence.
This was a description of a possible future problem, if there were a further cognitive deterioration; it does not inform a present adverse decision.
(3) The third problem is about delay and interim arrangements. Any referral clearly needs to await the new CCC being in post. Whenever a referral were made, it is known to take considerable time. That means there needs to be an interim arrangement. But what would it be? This has gone entirely unanswered. In the email on 25.3.24 the Claimant's solicitors said this:
In any event, if our client were re-referred to wheelchair services, this would likely be a protracted process it previously took 18 months. Nor would there be any interim provision pending resolution; please confirm whether the ICB can propose any viable alternatives?
In an email on 31.7.24 Ms Duggan asked:
please could you confirm what the "proposed interim arrangements" to address the delay would look like in practice?
These straightforward requests went unanswered. It was unreasonable for the Defendant not to identify an interim arrangement, which would be in place upon a referral being made. For this and the other reasons, the Defendant's response in excluding the wheelchair from the Plan and budget is outside the range of reasonable responses and unlawful.
Interim arrangements for meeting your wheelchair needs, insofar as they are required, can of course be explored with NHS wheelchair services following referral.
No referral was made, and no exploration of interim arrangements with NHS wheelchair services, "following referral", arose. There was and is no evidence that a referral would need to await a new CCC, or why that would be the case. This case would be different in its complexion if: (a) a referral had been made; (b) no suitable interim arrangement was available from NHS wheelchair services; (c) the Defendant had been requested to extend the Plan to fund the existing wheelchair; and (d) it had refused to do so. But that is not the position. It was not beyond the range of reasonable responses for the Defendant to decide that a wheelchair was available through NHS wheelchair services, and that interim post-referral provision should first be explored with NHS wheelchair services, notwithstanding the events of 2022. The relevance of the safety point is this. It illustrates the sorts of issue which it would be for NHS wheelchair services to address itself acting lawfully, reasonably and fairly as the public authority specialist arm dealing with wheelchairs. I am unable to see any unlawfulness in the Defendant's approach to the wheelchair. I accept the submissions of Mr Parkhill on this sixth part of the case.
Travel and Hotel Costs
(1) It is self-evident that the Claimant has an assessed need to travel to her medical appointments. The CCC's job description requires the CCC to travel with her to them too. The decision letter of 12.4.24 refuses the requests for transport costs and hotel stays, on the basis that they were not identified as reasonably required to meet an assessed health and care need within the CHC package of care. That decision is beyond the range of reasonable responses.
(2) Funding had previously been allowed. On 9.11.23 it was described as £400 per month transport (based on taxis to The Royal Brompton and for London appointments) and £400 per month hotels (based on twice-monthly stays in Bristol). On 22.9.23 it had been recorded as £400 per week for transport and £200 per week hotels. This is a clearly evidenced need. In an email dated 25.1.24, provided by her solicitor on 6.3.24, the Claimant identified the different hospitals she has to attend and their locations, and describing the arrangements for stays in hotels. Also before the decision-makers was the GP's letter of 18.10.23 describing the 17 clinical appointments which the Claimant had attended in 30 days. This funding was simply removed.
(3) There is no reasoning in the decision documents. There was no enquiry, exploring with the Claimant alternative sources of funding and the lived experience of trying to access them. Ms Lowe's witness statement describes making contact with Ms Duggan in relation to information gaps, but not in relation to travel and hotel costs. The only explanation Ms Lowe gives is this:
Ms Simpson is in receipt of benefits and owns a Motability vehicle which she can use to travel to appointments. She is funded for 2:1 support 24 hours a day and has a private electric wheelchair. There is no basis for a reasonable requirement for additional funding for transport costs to attend hospital appointments as this can be met through her personal finances and other benefits. At paragraph 46 of her witness statement of 19 April 2024, Ms Simpson has rightly identified that she has access to NHS funding for transport for appointments too. This is in the form of travel costs being reimbursed via the low-income funding scheme and also via hospital transport (though this appears not to have worked well for her in some cases). These schemes are not managed by the ICB and are properly the responsibility of the Trusts providing Ms Simpson's care and treatment.
(4) The problem with this reliance on alternatives is that they do not cover the transport costs. So far as benefits are concerned, the Claimant's third witness statement (31.10.24):
I am continuing to pay for my transport expenses out of my disability benefits, which includes PIP enhanced mobility component at a rate of £75.15 per week; however, this money is earmarked towards my Motability vehicle. It does not cover the additional costs of petrol.
So, this leaves the petrol costs entirely unfunded.
(5) Ms Lowe acknowledges that the hospital transport scheme have "not worked" for the Claimant. The Claimant's first witness statement (19.4.24) was clear and explicit:
I am getting pushed further and further into poverty due to these restrictions. I am entitled to hospital transport. So, there is the 'low income scheme' on the NHS which reimburses travel fares; but the issue I have is that you have to pay out for the travel fare before you are reimbursed. You wait sometimes 90 minutes at these cashier desks having to evidence need I am simply not well enough. I need the ICB to realise that this is my day-to-day reality
(6) The Defendant has failed to act reasonably. It did not undertake a reasonable enquiry. It has not appreciated that PIP enhanced mobility component is swallowed up by costs relating to the mobility vehicle, and does not cover any petrol. It has failed to appreciate that the NHS reimbursement schemes do not in practice work for the Claimant at all. The exclusion of transport costs, and hotel costs, is not a reasonable response.
6 December 2023 - £62.00 petrol
8 December 2023 Great Ormond Street Hospital 55 mile return journey
2 January 2024 Brompton hospital 66 mile return journey
9 January 2024 GP surgery in Brentwood 2 mile return journey
22 January 2024 Harold Wood clinic 10 mile return journey
5 February 2024 - £67.77 petrol
12 February 2024 Harold Wood clinic 10 mile return journey
22 February 2024 Hutton (dentist) 7 mile return journey
4 April 2024 Addenbrookes hospital 98 mile return journey
8 April 2024 Harold Wood clinic 10 mile return journey
18 April 2024 Brompton hospital 66 mile return journey
19 April 2024 National neurological hospital 60 mile return journey
30 April 2024 - £95.01 petrol
8 May 2024 National neurological hospital 60 mile return journey
14 May 2024 Brentwood community hospital 3 mile return journey
20 May 2024 Brompton hospital 66 mile return journey
13 May 2024 Basildon hospital 22 mile return journey
13 June 2024 - £94.77 petrol
19 June 2024 Brompton hospital 66 mile return journey
21 June 2024 Hutton (dentist) 7 mile return journey
24 June 2024 Moorfields hospital 52 mile return journey
30 June 2024 - £86.05 petrol
8 July 2024 Brompton hospital 66 mile return journey
11 July 2024 Addenbrookes 98 mile return journey
18 July 2024 Brompton hospital 66 mile return journey
29 August 2024 - £91.43 petrol
31 August 2024 National Neurological hospital 60 mile return journey
5 September 2024 Guys hospital 58 mile return journey
10 October 2024 Guys hospital 58 mile return journey
Conclusion
Order
Permission to appeal